U.S., April 28 -- ClinicalTrials.gov registry received information related to the study (NCT07552922) titled 'Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1' on Sept. 21, 2025.
Brief Summary: This study aims to explore the perceptions of men with prostate cancer (PCa) and high-risk biochemical recurrence (BCR) regarding the risk of breast-related side effects, including gynaecomastia, from treatment.
Study Start Date: Dec. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer (Adenocarcinoma)
Intervention:
OTHER: Semi-structured Interview
this t study will use qualitative methods to explore men's views of gynaecomastia from high-risk BCR PCa treatments (Stage 1) to inform attributes and leve...